X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1463) 1463
Book Review (298) 298
Publication (94) 94
Newsletter (6) 6
Conference Proceeding (4) 4
Book Chapter (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1228) 1228
humans (1056) 1056
clarithromycin (1005) 1005
helicobacter pylori (680) 680
male (591) 591
female (577) 577
helicobacter infections - drug therapy (540) 540
infection (477) 477
gastroenterology & hepatology (470) 470
anti-bacterial agents - therapeutic use (466) 466
middle aged (434) 434
adult (426) 426
helicobacter pylori - drug effects (414) 414
microbiology (374) 374
amoxicillin (367) 367
clarithromycin - therapeutic use (347) 347
drug therapy, combination (343) 343
pharmacology & pharmacy (325) 325
anti-bacterial agents - pharmacology (319) 319
metronidazole (308) 308
aged (301) 301
antibiotics (299) 299
eradication (294) 294
treatment outcome (293) 293
microbial sensitivity tests (267) 267
helicobacter infections - microbiology (256) 256
antibiotic-resistance (254) 254
anti-bacterial agents - administration & dosage (245) 245
clarithromycin - pharmacology (240) 240
drug resistance, bacterial (232) 232
triple therapy (230) 230
helicobacter infections (226) 226
clarithromycin - administration & dosage (217) 217
infectious diseases (215) 215
resistance (212) 212
therapy (195) 195
health aspects (187) 187
amoxicillin - therapeutic use (185) 185
helicobacter pylori - isolation & purification (185) 185
infections (182) 182
levofloxacin (179) 179
adolescent (175) 175
prevalence (175) 175
drug resistance in microorganisms (173) 173
antimicrobial resistance (162) 162
clarithromycin resistance (160) 160
drug resistance (159) 159
management (151) 151
metaanalysis (143) 143
omeprazole (143) 143
azithromycin (140) 140
prospective studies (139) 139
efficacy (138) 138
care and treatment (134) 134
amoxicillin - administration & dosage (133) 133
antibiotic resistance (131) 131
analysis (129) 129
abridged index medicus (126) 126
young adult (125) 125
animals (122) 122
children (122) 122
proton pump inhibitors - therapeutic use (122) 122
metronidazole - therapeutic use (121) 121
drug administration schedule (118) 118
drug therapy (116) 116
susceptibility (115) 115
helicobacter infections - diagnosis (114) 114
child (111) 111
sequential therapy (109) 109
biopsy (108) 108
strains (106) 106
helicobacter pylori - genetics (105) 105
antibacterial agents (104) 104
anti-bacterial agents - adverse effects (102) 102
quadruple therapy (102) 102
aged, 80 and over (101) 101
helicobacter infections - epidemiology (101) 101
erythromycin (100) 100
research (98) 98
bacteria (96) 96
medicine & public health (96) 96
antimicrobial agents (95) 95
diagnosis (92) 92
proton pump inhibitors (91) 91
medicine, general & internal (90) 90
internal medicine (88) 88
macrolides (88) 88
breath tests (86) 86
metronidazole - administration & dosage (84) 84
mutation (84) 84
bismuth (82) 82
ulcers (82) 82
urea (81) 81
dosage and administration (80) 80
metronidazole - pharmacology (79) 79
proton pump inhibitor (78) 78
amoxicillin - pharmacology (77) 77
patients (76) 76
proton pump inhibitors - administration & dosage (76) 76
drug resistance, microbial (75) 75
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1450) 1450
Spanish (10) 10
German (3) 3
Korean (3) 3
Japanese (2) 2
Chinese (1) 1
French (1) 1
Italian (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Internal Medicine, ISSN 0953-6205, 2016, Volume 32, pp. 84 - 90
Abstract Background Currently only a few studies compare sequential and concomitant non-bismuth Helicobacter pylori therapies referring to high antibiotic... 
Internal Medicine | H. pylori treatment | Sequential treatment | First line | Concomitant treatment | Metronidazole resistance | Clarithromycin resistance | 14-DAY TRIPLE | 1ST-LINE TREATMENT | MULTICENTER | METAANALYSIS | REGIMEN | STANDARD TRIPLE THERAPY | RATES | MEDICINE, GENERAL & INTERNAL | INFECTION | HYBRID THERAPY | DURATION | Esomeprazole - administration & dosage | Humans | Middle Aged | Carbon Isotopes | Drug Resistance, Bacterial | Male | Helicobacter Infections - pathology | Helicobacter pylori | Peptic Ulcer - microbiology | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Adult | Female | Helicobacter Infections - metabolism | Urea - metabolism | Amoxicillin - administration & dosage | Drug Therapy, Combination | Dyspepsia - drug therapy | Metronidazole - administration & dosage | Breath Tests | Dyspepsia - microbiology | Pyloric Antrum - pathology | Biopsy | Aged | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Clinical trials | Drug resistance in microorganisms | Clarithromycin | Index Medicus | Helicobacter Infections/drug therapy | Peptic Ulcer/drug therapy | Proton Pump Inhibitors/administration & dosage | Helicobacter Infections/pathology | Peptic Ulcer/microbiology | Tissues and Organs | Life Sciences | Esomeprazole/administration & dosage | Hépatology and Gastroenterology | Pyloric Antrum/pathology | Anti-Bacterial Agents/administration & dosage | Dyspepsia/microbiology | Helicobacter Infections/metabolism | Bacteriology | Clarithromycin/administration & dosage | Urea/metabolism | Metronidazole/administration & dosage | Microbiology and Parasitology | Human health and pathology | Amoxicillin/administration & dosage | Dyspepsia/drug therapy
Journal Article
Helicobacter, ISSN 1083-4389, 12/2013, Volume 18, Issue 6, pp. 459 - 467
BackgroundIncreasing clarithromycin resistance reduces Helicobacter pylori eradication rates with conventional triple regimens. We evaluated effectiveness and... 
treatment | concomitant therapy | clarithromycin resistance | second line | H. pylori | first line | dual resistance | H. pylori treatment | Second line | First line | Concomitant therapy | Dual resistance | Clarithromycin resistance | QUADRUPLE CONCOMITANT THERAPY | EFFICACY | ANTIBIOTIC-RESISTANCE | RANDOMIZED-TRIAL | MICROBIOLOGY | SEQUENTIAL THERAPY | pylori treatment | CONSENSUS REPORT | STANDARD TRIPLE THERAPY | LEVOFLOXACIN | INFECTION | 1ST-LINE | GASTROENTEROLOGY & HEPATOLOGY | Prospective Studies | Humans | Middle Aged | Drug Resistance, Bacterial | Helicobacter pylori - drug effects | Male | Clarithromycin - therapeutic use | Esomeprazole - therapeutic use | Young Adult | Anti-Bacterial Agents - therapeutic use | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Amoxicillin - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Helicobacter pylori - physiology | Drug Therapy, Combination | Helicobacter Infections - microbiology | Urea | Proton pump inhibitors | Clarithromycin | Helicobacter pylori | Amoxicillin | Index Medicus | Helicobacter Infections/drug therapy | Amoxicillin/therapeutic use | Helicobacter Infections/microbiology | Helicobacter pylori/physiology | Metronidazole/therapeutic use | Bacteriology | Helicobacter pylori/drug effects | Life Sciences | Clarithromycin/therapeutic use | Microbiology and Parasitology | Esomeprazole/therapeutic use | Anti-Bacterial Agents/therapeutic use
Journal Article
Annals of Gastroenterology, ISSN 1108-7471, 03/2018, Volume 31, Issue 2, pp. 205 - 210
Hybrid therapy is a promising first-line regimen for ( ) eradication. We evaluated a hybrid therapy, assessing the impact of antibiotic resistance on... 
Clarithromycin | Hybrid therapy | Metronidazole | Helicobacter pylori | Antibiotic resistance | Dual resistance | hybrid therapy | antibiotic resistance | metronidazole | dual resistance | clarithromycin | Original
Journal Article
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 03/2015, Volume 41, Issue 6, pp. 581 - 589
Journal Article
Journal Article
Journal Article
by Wang, D and Guo, QQ and Yuan, Y and Gong, YH
BMC MICROBIOLOGY, ISSN 1471-2180, 07/2019, Volume 19, Issue 1, pp. 152 - 152
BackgroundH. pylori exhibits antibiotic resistance with regional differences. In this paper, we explored antibiotic resistance of H. pylori to five antibiotics... 
CLARITHROMYCIN | STRAINS | VACA | CAGA GENE | High-risk area of gastric cancer | MICROBIOLOGY | ANTIMICROBIAL RESISTANCE | LEVOFLOXACIN | Virulence factors | Antibiotic resistance | pylori | TRIPLE THERAPY | ERADICATION THERAPY | METRONIDAZOLE | PEPTIC-ULCER | Prevention | Drug resistance in microorganisms | Care and treatment | Helicobacter pylori | Research | Stomach cancer | Risk factors | H. pylori
Journal Article
ZEITSCHRIFT FUR GASTROENTEROLOGIE, ISSN 0044-2771, 03/1997, Volume 35, Issue 3, pp. 165 - 169
Basic problem and objective of study: The situation of pretherapeutical antimicrobial drug resistance of Helicobacter pylori has therapeutical implications.... 
ANTIBIOTICS | EFFICACY | TISSUE | OMEPRAZOLE | clarithromycin | antimicrobial drug resistance | IMPACT | Helicobacter pylori | TRIPLE THERAPY | metronidazole | ERADICATION | INFECTION | METRONIDAZOLE RESISTANCE | GASTROENTEROLOGY & HEPATOLOGY
Journal Article
Zeitschrift fur Gastroenterologie, ISSN 0044-2771, 03/1997, Volume 35, Issue 3, p. 165
Journal Article
Journal Article
Journal Article
Journal Article